CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 174 enrolled
Drug / intervention
Formoterol Fumarate in the Pressair DPI, Low Dose +4 moredrug
Likely dose
Formoterol Fumarate in the Pressair DPI, Low Dose 6 microgramsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01641081
NCT01641081Phase 2Completed

Phase II, Randomized, Placebo-controlled, Double-blind, Double-dummy, 5-period Complete Crossover Study of the Bronchodilator Effects of Formoterol Fumarate Inhalation Powder in Patients With Mild to Moderate Asthma.

AstraZeneca·interventional·Posted Jul 16, 2012·Updated Feb 28, 2017

In Brief

A Phase 2 clinical trial evaluating Formoterol Fumarate in the Pressair DPI, Low Dose, Formoterol Fumarate in the Pressair DPI, High Dose, and 3 other interventions for Asthma. Completed, enrolled 174 participants across 29 sites.

Detailed Summary

The purpose of this Phase II study is to evaluate efficacy and safety of inhaled formoterol fumarate in the Pressair DPI compared to the Foradil Aerolizer in patients with mild to moderate asthma. This study will include a screening visit followed by a 4 month treatment period.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 16, 2012
Enrollment StartJun 1, 2012
Primary CompletionFeb 1, 2013
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 14.0 years ago

Interventions

Formoterol Fumarate in the Pressair DPI, Low Dosedrug

Formoterol Fumarate in the Pressair DPI 6 micrograms, twice a day for 14 days

Formoterol Fumarate in the Pressair DPI, High Dosedrug

Formoterol Fumarate in the Pressair DPI 12 micrograms, twice a day for 14 days

Foradil Aerolizer, Low Dosedrug

Foradil Aerolizer 12 micrograms, twice a day for 14 days

Foradil Aerolizer, High Dosedrug

Foradil Aerolizer 24 micrograms, twice per day for 14 days

Placebodrug

Placebo in the Pressair for 14 days